Particularly, around 40% of T-LGLL cases harbor activating mutations in the signal transducer and activator of the transcription 3 (STAT3) gene while the remaining patients present with wild-type STAT3 [6, 7]. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.